K E de Visser - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Leukemia|August 18, 1999

Effects of TGF-beta on the immune system: implications for cancer immunotherapyK E de Visser, W M Kast

Cancer Immunology, Immunotherapy : CII|May 13, 2005

The interplay between innate and adaptive immunity regulates cancer developmentK E de Visser, L M Coussens

Biologicals : Journal of the International Association of Biological Standardization|February 20, 2002

Circumventing T-cell tolerance to tumour antigensH W Kessels, K E de Visser, A M Kruisbeek, et al.

European Journal of Immunology|May 23, 2000

Tracing and characterization of the low-avidity self-specific T cell repertoireK E de Visser, T A Cordaro, D Kioussis, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001

Low-avidity self-specific T cells display a pronounced expansion defect that can be overcome by altered peptide ligandsK E de Visser, T A Cordaro, H W Kessels, et al.

European Journal of Immunology|May 23, 2000

Tumor size at the time of adoptive transfer determines whether tumor rejection occursT A Cordaro, K E de Visser, F H Tirion, et al.

Journal of Cellular Biochemistry|May 5, 1999

Chimeric papillomavirus virus-like particles induce a murine self-antigen-specific protective and therapeutic antitumor immune responseJ D Nieland, D M Da Silva, M P Velders, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001

A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacyL A Small, D M Da Silva, K E de Visser, et al.

Critical Reviews in Immunology|January 7, 1998

Identification of peptides for immunotherapy of cancer. It is worth the effortM P Velders, J D Nieland, M P Rudolf, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor modelH L Greenstone, J D Nieland, K E de Visser, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Leukemia|August 18, 1999

Effects of TGF-beta on the immune system: implications for cancer immunotherapyK E de Visser, W M Kast

Cancer Immunology, Immunotherapy : CII|May 13, 2005

The interplay between innate and adaptive immunity regulates cancer developmentK E de Visser, L M Coussens

Biologicals : Journal of the International Association of Biological Standardization|February 20, 2002

Circumventing T-cell tolerance to tumour antigensH W Kessels, K E de Visser, A M Kruisbeek, et al.

European Journal of Immunology|May 23, 2000

Tracing and characterization of the low-avidity self-specific T cell repertoireK E de Visser, T A Cordaro, D Kioussis, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001

Low-avidity self-specific T cells display a pronounced expansion defect that can be overcome by altered peptide ligandsK E de Visser, T A Cordaro, H W Kessels, et al.

European Journal of Immunology|May 23, 2000

Tumor size at the time of adoptive transfer determines whether tumor rejection occursT A Cordaro, K E de Visser, F H Tirion, et al.

Journal of Cellular Biochemistry|May 5, 1999

Chimeric papillomavirus virus-like particles induce a murine self-antigen-specific protective and therapeutic antitumor immune responseJ D Nieland, D M Da Silva, M P Velders, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001

A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacyL A Small, D M Da Silva, K E de Visser, et al.

Critical Reviews in Immunology|January 7, 1998

Identification of peptides for immunotherapy of cancer. It is worth the effortM P Velders, J D Nieland, M P Rudolf, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor modelH L Greenstone, J D Nieland, K E de Visser, et al.

Pageof 2